Literature DB >> 23046135

Non-catalytic tyrosine-phosphorylated receptors.

Omer Dushek1, Jesse Goyette, P Anton van der Merwe.   

Abstract

Leukocytes play a critical role in recognizing and responding to infection and cancer. Central to this function is an array of cell-surface receptors that lack sequence homology. Many of these receptors have in common the fact that their signaling involves phosphorylation of cytoplasmic domains by extrinsic tyrosine kinases. These non-catalytic tyrosine-phosphorylated receptors (NTRs) share a number of other features, including small size and optimal stimulation by surface-associated ligands. We argue here that NTRs are also likely to share the same kinetic-segregation triggering mechanism, which involves segregation of the engaged NTR from receptor tyrosine phosphatases with large ectodomains such as CD45 and CD148. NTRs signal through tyrosine-containing cytoplasmic motifs, which recruit distinct cytoplasmic signaling proteins when phosphorylated, transducing activatory or inhibitory signals. They have two features that make them uniquely well suited to their role in immune recognition of infection and cancer. Their modular structure enables the coupling of many rapidly evolving receptors with diverse ligand specificities to the same conserved signaling machinery. Their similarity in size and shared signaling machinery enables them to colocalize at cell-cell interfaces when they engage ligands, facilitating the integration of activatory and inhibitory signals from multiple receptors at the cell surface.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046135     DOI: 10.1111/imr.12008

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  41 in total

1.  Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets.

Authors:  Matthew H Bakalar; Aaron M Joffe; Eva M Schmid; Sungmin Son; Marija Podolski; Daniel A Fletcher
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

2.  The catalytic activity of the kinase ZAP-70 mediates basal signaling and negative feedback of the T cell receptor pathway.

Authors:  Hanna Sjölin Goodfellow; Maria P Frushicheva; Qinqin Ji; Arup K Chakraborty; Arthur Salomon; Arthur Weiss; Debra A Cheng; Theresa A Kadlecek; Aaron J Cantor; John Kuriyan
Journal:  Sci Signal       Date:  2015-05-19       Impact factor: 8.192

3.  Reductionism Is Dead: Long Live Reductionism! Systems Modeling Needs Reductionist Experiments.

Authors:  James R Faeder; Penelope A Morel
Journal:  Biophys J       Date:  2016-04-26       Impact factor: 4.033

Review 4.  Mass Spectrometry-Based Protein Footprinting for Higher-Order Structure Analysis: Fundamentals and Applications.

Authors:  Xiaoran Roger Liu; Mengru Mira Zhang; Michael L Gross
Journal:  Chem Rev       Date:  2020-04-22       Impact factor: 60.622

5.  Insights into immune structure, recognition, and signaling.

Authors:  K Christopher Garcia
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

6.  The Beacon Calculus: A formal method for the flexible and concise modelling of biological systems.

Authors:  Michael A Boemo; Luca Cardelli; Conrad A Nieduszynski
Journal:  PLoS Comput Biol       Date:  2020-03-09       Impact factor: 4.475

7.  Non-receptor-tyrosine kinases integrate fast glucocorticoid signaling in hippocampal neurons.

Authors:  Silei Yang; Francesco Roselli; Alexandre V Patchev; Shuang Yu; Osborne F X Almeida
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

8.  Programmable polyproteams built using twin peptide superglues.

Authors:  Gianluca Veggiani; Tomohiko Nakamura; Michael D Brenner; Raphaël V Gayet; Jun Yan; Carol V Robinson; Mark Howarth
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

9.  T-Cell Receptor Ligands: Every which Way They Can.

Authors:  Simon J Davis; Caitlin O'Brien-Ball
Journal:  Biophys J       Date:  2020-05-20       Impact factor: 4.033

10.  CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action.

Authors:  Lee I Garner; Andrew Hartland; Johannes Breuning; Marion H Brown
Journal:  Immunology       Date:  2018-06-13       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.